摘要 |
A compound of formula (I) wherein: R<SUP>1 </SUP>is an aryl group, unsubstituted or substituted by 1, 2, 3 or 4 substituents which may be the same or different selected from the group consisting of C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl, C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, C<SUB>1</SUB>-C<SUB>6 </SUB>alkylthio, aryl C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, hydroxy, halo, CN, COR<SUP>6</SUP>, COOR<SUP>6</SUP>, NR<SUP>6</SUP>COR<SUP>7</SUP>, CONR<SUP>8</SUP>R<SUP>9</SUP>, SO<SUB>2</SUB>NR<SUP>8</SUP>R<SUP>9</SUP>, NR<SUP>6</SUP>SO<SUB>2</SUB>R<SUP>7</SUP>, NR<SUP>8</SUP>R<SUP>9</SUP>, halo C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, and halo C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxy; W is CH and X is N, or W is N and X is CH, or W and X are CH; Y is C<SUB>2</SUB>-C<SUB>4</SUB>alkyl, R<SUP>2 </SUP>is hydrogen, C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl, C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, C<SUB>1</SUB>-C<SUB>6 </SUB>alkylthio, aryl C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, hydroxy, halo, CN, COR<SUP>6</SUP>, carboxy, COOR<SUP>6</SUP>, NR<SUP>6</SUP>COR<SUP>7</SUP>, CONR<SUP>8</SUP>R<SUP>9</SUP>, SO<SUB>2</SUB>NR<SUP>8</SUP>R<SUP>9</SUP>, NR<SUP>6</SUP>SO<SUB>2</SUB>R<SUP>7</SUP>, NR<SUP>8</SUP>R<SUP>9</SUP>, mono to perfluoro-C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl, or mono to perfluoro-C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy; n is 0-5; R<SUP>3 </SUP>is C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl; R<SUP>4 </SUP>is C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl; R<SUP>5 </SUP>is hydrogen, C<SUB>1</SUB>-C<SUB>10 </SUB>alkyl, C<SUB>2</SUB>-C<SUB>10 </SUB>alkenyl, C<SUB>2</SUB>-C<SUB>10 </SUB>alkynyl, halo C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, C<SUB>3</SUB>-C<SUB>8 </SUB>cycloalkyl, C<SUB>3</SUB>-C<SUB>8 </SUB>cycloalkyl, C<SUB>3</SUB>-C<SUB>8 </SUB>cycloalkyl C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, C<SUB>5</SUB>-C<SUB>8</SUB>cycloalkenyl, C<SUB>5</SUB>-C<SUB>8</SUB>cycloalkenyl C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, 3-8-membered heterocycloalkyl, 3-8-membered heterocycloalkyl C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, C<SUB>6</SUB>-C<SUB>14 </SUB>aryl, C<SUB>6</SUB>-C<SUB>14 </SUB>aryl C<SUB>1</SUB>-C<SUB>10 </SUB>alkyl, heteroaryl, or heteroaryl C<SUB>1</SUB>-C<SUB>10</SUB>alkyl; wherein each group is optionally one or more times by the same and/or a different group which is C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, C<SUB>1</SUB>-C<SUB>6 </SUB>alkylthio, aryl C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, hydroxy, halo, CN, NR<SUP>8</SUP>R<SUP>9</SUP>, or halo C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxy R<SUP>6 </SUP>and R<SUP>7 </SUP>are independently hydrogen or C<SUB>1</SUB>-C<SUB>10 </SUB>alkyl; R<SUP>8 </SUP>and R<SUP>9 </SUP>are the same or different and are hydrogen or C<SUB>1</SUB>-C<SUB>10 </SUB>alkyl, or R<SUP>9 </SUP>and R<SUP>10 </SUP>together with the nitrogen to which they are attached form a 5- to 7 membered ring optionally containing one or more further heteroatoms selected from oxygen, nitrogen and sulphur, and optionally substituted by one or two substituents selected from the group consisting of hydroxy, oxo, C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, C<SUB>1</SUB>-C<SUB>4 </SUB>alkylcarboxy, aryl, and aryl C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl; or a pharmaceutically acceptable salt thereof. These compounds are useful for treating atherosclerosis or other inflammatory diseases.
|